上海中医药大学附属曙光医院肝病科,上海市浦东新区张衡路528号,201203
gaoyueqiu@hotmail.com
收稿:2025-04-18,
修回:2025-07-10,
纸质出版:2025-10-02
移动端阅览
陈博武,李曼,朱晓骏等.慢性乙型病毒性肝炎肝纤维化患者644例病机特征及演变规律研究[J].中医杂志,2025,66(19):2030-2036.
CHEN Bowu,LI Man,ZHU Xiaojun,et al.Pathogenesis Characteristics and Progression Patterns of Liver Fibrosis in 644 Patients with Chronic Hepatitis B[J].Journal of Traditional Chinese Medicine,2025,66(19):2030-2036.
陈博武,李曼,朱晓骏等.慢性乙型病毒性肝炎肝纤维化患者644例病机特征及演变规律研究[J].中医杂志,2025,66(19):2030-2036. DOI: 10.13288/j.11-2166/r.2025.19.011.
CHEN Bowu,LI Man,ZHU Xiaojun,et al.Pathogenesis Characteristics and Progression Patterns of Liver Fibrosis in 644 Patients with Chronic Hepatitis B[J].Journal of Traditional Chinese Medicine,2025,66(19):2030-2036. DOI: 10.13288/j.11-2166/r.2025.19.011.
目的
2
分析慢性乙型病毒性肝炎(CHB)肝纤维化患者的中医证候规律。
方法
2
纳入2019年1月1日至2023年12月31日在全国17家三级甲等中医医院就诊的CHB且肝组织病理肝纤维化分期S1~S4期的患者644例,收集患者的基本资料、临床资料、临床症状等信息建立数据库。提取临床常见症状,采用主成分分析法提取因子,通过因子分析和聚类分析,综合各公因子的病位、病性、病邪证候要素情况,并经专家讨论后归纳为若干个中医证型,总结CHB肝纤维化患者中医证候分类特征,并比较不同纤维化分期、炎症分级患者的中医证候分布特点。
结果
2
排名前5位的症状分别为倦怠乏力、小便发黄、口干、视物疲劳、口苦。以各个症状变量作为因子进行因子分析,获得11个公因子(
P
<0.001),累积贡献率达60.479%。公因子的病位证素以肝、脾、肾为主,病性证素以气虚、阴虚、血瘀、湿热为主。对11个公因子进行聚类分析,经专家讨论后归纳为四类中医证候,分别是脾肾亏虚证(262例,40.68%)、肝郁脾虚证(156例,24.22%)、肝经湿热证(142例,22.05%)、肝脾血瘀证(84例,13.04%)。不同性别、不同年龄、不同体重指数分级、乙型肝炎E抗原阴性/阳性患者及不同肝组织病理炎症分级间中医证型分布差异无统计学意义(
P
>0.05)。在不同肝组织
病理肝纤维化分期患者中,四种证型分布特征差异有统计学意义(
P
=0.034)。随着纤维化程度的升高(S1→S4),虚证患者的比例随之升高。
结论
2
CHB肝纤维化患者的病位主要在肝、脾、肾,主要病机为脾肾亏虚兼湿热、血瘀,中医证候可分为脾肾亏虚证、肝郁脾虚证、肝经湿热证、肝脾血瘀证,其中脾肾亏虚证最为常见。
Objective
2
To analyze the traditional Chinese medicine (TCM) syndromes rules in patients with liver fibrosis of chronic hepatitis B (CHB).
Methods
2
A total of 644 chronic hepatitis B (CHB) patients with liver fibrosis stages S1~S4 on histopathological examination were recruited from January 1, 2019, to December 31, 2023, across 17 tertiary-level Class A TCM hospitals nationwide. A database was established containing patients' basic information, clinical data, and clinical symptoms. Common clinical symptoms were extracted using principal component analysis to identify factors. Through factor analysis and cluster analysis, the pathological location, nature, and pathogenic symptoms of each common factor were comprehensively evaluated. Following expert discussion, these factors were categorized into several TCM syndrome patterns. The classification characteristics of TCM syndromes in CHB patients with liver fibrosis were summarized, and the distribution patterns of TCM syndromes were compared across different fibrosis stages and inflammation grades.
Results
2
The top 5 symptoms were fatigue, yellow urination, dry mouth, visual fatigue and bitter mouth. Factor analysis with each symptom showed that 11 common factors were obtained (
P
<0.001), with a cumulative contribution rate of 60.479%. The disease location elements mainly involved liver, spleen and kidney, while the disease characteristic elements mainly include
qi
deficiency,
yin
deficiency, blood stasis and dampness-heat. After cluster analysis of 11 common factors, it was summarized into four types of TCM syndromes after expert discussion, which are spleen-kidne
y deficiency syndrome (262 cases, 40.68%), liver depression and spleen deficiency syndrome (156 cases, 24.22%), dampness-heat in liver meridian syndrome (142 cases, 22.05%), spleen-liver depression and blood stasis syndrome (84 cases, 13.04%). There was no significant difference in the distribution of TCM syndromes among gender, age, BMI grade, as well as HBeAg negative/positive status and hepatic tissue histopathological inflammation grades (
P
>0.05). There were statistically significant differences in the distribution characteristics of the four syndrome types in patients with different liver fibrosis stages (
P
= 0.034). As the degree of fibrosis processed (S1 to S4), the proportion of patients with deficiency syndrome increased.
Conclusion
2
The pathological locations of liver fibrosis of CHB primarily involve the liver, spleen, and kidneys. The main pathogenesis are spleen-kidney deficiency, as well as dampness-heat and blood stasis. TCM syndromes can be divided into spleen-kidney deficiency syndrome, liver depression and spleen deficiency syndrome, dampness-heat in the liver meridian syndrome, and liver-spleen blood stasis syndrome, among which pattern of spleen-kidney deficiency syndrome is the most common.
World Health Organization . Global progress report on HIV , viral hepatitis and sexually transmitted infections, 2021 . Accountability for the global health sector strategies 2016 -2021:actions for impact [EB/OL]. ( 2022-12-24 )[ 2024-11-28 ]. https://apps.who.int/iris/bitstream/hand le/10665/342808/9789240030985-eng.pdf https://apps.who.int/iris/bitstream/handle/10665/342808/9789240030985-eng.pdf .
HUI Z , YU W , FUZHEN W , et al . New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020 [J]. Lancet Reg Health West Pac , 2024 , 51 : 101193 . doi: 10.1016/j.lanwpc.2024. 101193 http://dx.doi.org/10.1016/j.lanwpc.2024.101193 .
PINZANI M , ROMBOUTS K . Liver fibrosis: from the bench to clinical targets [J]. Dig Liver Dis , 2004 , 36 ( 4 ): 231 - 242 .
萧焕明 , 施梅姐 , 谢玉宝 , 等 . 慢性乙型肝炎相关肝纤维化中医诊疗进展与思考 [J]. 临床肝胆病杂志 , 2023 , 39 ( 2 ): 260 - 266 .
中华医学会肝病学分会 , 中华医学会感染病学分会 . 慢性乙型肝炎防治指南(2022年版) [J]. 实用肝脏病杂志 , 2023 , 26 ( 3 ): 457 - 478 .
吴孟超 , 李梦东 . 实用肝病学 [M]. 北京 : 人民卫生出版社 , 2011 : 498 - 776 .
中国中西医结合学会肝病专业委员会 . 肝纤维化中西医结合诊疗指南(2019年版) [J]. 临床肝胆病杂志 , 2019 , 35 ( 7 ): 1444 - 1449 .
中华医学会感染病学分会 , 中华医学会肝病学分会 . 慢性乙型肝炎防治指南(2019年版) [J]. 临床肝胆病杂志 , 2019 , 35 ( 12 ): 2648 - 2669 .
周仲瑛 . 中医内科学 [M]. 北京 : 中国中医药出版社 , 2003 : 287 - 294 .
郑筱萸 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 : 143 - 151 .
邓铁涛 . 中医诊断学 [M]. 上海 : 上海科学技术出版社 , 1984 : 60 - 74 .
朱文锋 . 证素辨证学 [M]. 北京 : 人民卫生出版社 , 2008 : 88 - 161 .
朱晓骏 , 张景豪 , 孙学华 , 等 . 补肾健脾利湿法治疗慢性乙型肝炎临床效果及相关机制研究 [J]. 临床肝胆病杂志 , 2023 , 39 ( 6 ): 1274 - 1279 .
李玉瑶 , 王灵台 , 高月求 , 等 . 王灵台基于“当归活血,丹参和血”理论辨治慢性肝病经验 [J]. 上海中医药杂志 , 2023 , 57 ( 5 ): 8 - 11 .
李思泽 , 李小科 , 杜宏波 , 等 . 慢性乙型肝炎中医证型及证素分布规律研究 [J]. 中西医结合肝病杂志 , 2024 , 34 ( 10 ): 875 - 878 .
房经富 . 慢性病毒性乙型肝炎肝纤维化的中医证候特点探讨 [J]. 中外医疗 , 2017 , 36 ( 2 ): 19 - 21 .
刘二丽 , 汪晓军 . 451例慢性乙型病毒性肝炎患者中医证型分布及与临床检验指标的相关性 [J]. 中华中医药杂志 , 2019 , 34 ( 4 ): 1793 - 1795 .
叶永安 , 刘蕊洁 , 杨先照 , 等 . 乙型肝炎肝硬化中医证型、证素分布特点文献研究 [J]. 中医杂志 , 2020 , 61 ( 4 ): 346 - 350 .
余思邈 , 丁霞 , 李萍 , 等 . 慢性乙型肝炎恶性转化过程证候、证素演变规律的临床研究 [J]. 中医杂志 , 2023 , 64 ( 23 ): 2427 - 2434 .
中国医师协会中西医结合医师分会肝病学专家委员会 . 慢性乙型肝炎中西医结合诊疗专家共识 [J]. 临床肝胆病杂志 , 2024 , 40 ( 5 ): 884 - 892 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号